11/25/2025
A recent study shows that an AI tool called BioMapAI can identify people with ME/CFS with 90% accuracy by analyzing stool, blood, and other routine lab data.
Developed by researchers at the Jackson Laboratory and Duke University School of Medicine, BioMapAI integrated multi-omics data from 153 ME/CFS patients and 96 controls, revealing how disruptions across the microbiome, immune system, and metabolism are linked to fatigue, pain, sleep, and emotional symptoms.
The study underscores that ME/CFS may not have a single biomarker but rather a network of systems out of balance, requiring multiple interventions to restore health.
Stay informed on the latest IACC research and sign up for our email list through the link in our bio.
👉 Learn how AI is helping map complex disease biology. Read the full study: https://doi.org/10.1038/s41591-025-03788-3